Effect of Boceprevir on HCV-specific T Cell Responses
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Analysis of HCV-specific T cell responses in patients treated with boceprevir to assess
whether therapy can induce restoration of the T cell function and to what extent this
recovery can be achieved